Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial

First Page		Document Content
Endometrial cancer Uterine serous carcinoma Adjuvant therapy Uterine cancer Lung cancer Serous carcinoma Uterine clear cell carcinoma Raja M. Flores Gynaecological cancer Medicine Oncology		Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial Add to Reading List Source URL: www.ro-journal.com Download Document from Source Website File Size: 360,99 KB Share Document on Facebook

	1 Dr Carcangiu Maria Luisa Director Anatomic Patholgy I, Department of Pathology, Fondazione IRCCS Istituto Nazionale Tumori Via Venezian n.1 DocID: 1nPen - View Document
	CHAPTER 3 Tumours of the Fallopian Tube and Uterine Ligaments Tumours of the fallopian tube are much less common than the corresponding ovarian neoplasms; however, histologically the same surface epithelial-stromal tumou DocID: 15827 - View Document
	The American College of Obstetricians and Gynecologists WOMEN’S HEALTH CARE PHYSICIANS P RACTICE BULLET IN clinical management guidelines for obstetrician – gynecologists DocID: 14e0d - View Document
	Radiochemoimmunotherapy with intensity-modulated concomitant boost: interim analysis of the REACH trial DocID: 13gS8 - View Document
	PETER BAKER forefront “It’s a unique opportunity for our USC patients because we will soon be able to translate our discoveries into novel therapeutics that will improve patient outcomes.” DocID: RWfZ - View Document